Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
GlaxoSmithKline K.K., the Japan arm of GlaxoSmithKline PLC, said on March 6 that Kanako Kikuchi, director for strategy, marketing, and multi-channel, will become its president effective April 1. Ms Kikuchi will take over the reins from Philippe Fauchet, who will…
To read the full story
Related Article
- GSK Japan Pres. Kikuchi to Quit after Only 9 Months in Office
December 20, 2017
- GSK Poised to Re-Enter Japan Oncology Space with Novel Myeloma Drug
December 6, 2017
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





